Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Vivek
Nov 28, 2023, 16:43 |
Drugs
Vivek Subbiah: Pleased to share our review on RET inhibitors
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on RET inhibitors and RET inhibitor…
Nov 27, 2023, 17:17 |
Insight
Vivek Subbiah: Treatment patterns and overall survival (OS) in patients with advanced NSCLC in three countries between 2011 and 2020
Vivek Subbiah shared on LinkedIn: “Pleased to share our paper in American Cancer Society journal…
Nov 26, 2023, 15:32 |
Blog
Vivek Subbiah: This review delves into the evolution of basket trials in cancer drug development
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn:…
Nov 22, 2023, 02:38 |
Blog
Vivek Subbiah: When JAMA publishes a phase 1 study, it will be a practice-changing study in the future- Lepodisiran
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on…
Nov 21, 2023, 13:57 |
Blog
Vivek Subbiah: Honored to co-author with brilliant "Guru" of bladder cancer Guru Sonpavde.
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 20, 2023, 03:35 |
Insight
Vivek Subbiah: This Review summarizes the evidence regarding the use of VAF as a predictive biomarker
Vivek Subbiah shared on LinkedIn: "Pleased to share our paper in Cell Press Journal Trends…
Nov 13, 2023, 19:33 |
Blog
Vivek Subbiah: Think Tank on Advancing precision medicine in Rare cancers spearheaded by the amazing Jim Palma and Razelle Kurzrock
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…
Nov 13, 2023, 12:58 |
Blog
Vivek Subbiah: Incredible meeting of the Early Phase Drug Development minds
Vivek Subbiah shared on LinkedIn: “Wow! Incredible meeting of the Early Phase Drug Development minds.…
Nov 9, 2023, 23:40 |
Blog
Vivek Subbiah: A study in the United States, Canada, & Germany using retrospective real-world databases
Vivek Subbiah, made the following post on Twitter: "Hot off the press: Pleased to share…
Nov 9, 2023, 19:17 |
Opinion
Vivek Subbiah: Feeling grateful to have a brilliant and forward-thinking global expert in GU as a close friend Neeraj Agarwal
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, posted the following…
17
18
19
20
21
All:
301
Posts:
181 - 190
Highlights on the U.S. - India Cancer Moonshot Dialogue
The Nobel Prize: "Without him my kids wouldn’t be here" - cancer survivor Sharon Belvin
The plight of cancer patients in war-torn regions highlight the urgent need for our collective support - UICC
Top 100 Xfluencers in Sarcoma: Key Opinion Leaders to follow on X (Twitter) in 2024
A Manifesto to Improve Cancer Care in Conflict-Affected Areas: The Lancet
Facebook
RSS Feed
Twitter
Linkedin
Youtube